Efficacy of olmesartan and nifedipine on recurrent hypoxia-induced left ventricular remodeling in diabetic mice

Life Sciences

Volumn 86, Issue 9-10, 2010, Pages 322-330

  Yamashita, Chika ^a   Hayashi, Tetsuya ^a   Mori, Tatsuhiko ^a   Matsumoto, Chika ^a   Kitada, Kento ^a   Miyamura, Masatoshi ^a   Sohmiya, Koichi ^a   Ukimura, Akira ^a   Okada, Yoshikatsu ^a   Yoshioka, Toshitaka ^a   Kitaura, Yasushi ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Hypoxia; Oxidative stress; Remodeling

Indexed keywords

4 HYDROXYNONENAL; GELATINASE B; NIFEDIPINE; OLMESARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPOXEMIA; MALE; MONOTHERAPY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANOXIA; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DRUG THERAPY, COMBINATION; IMIDAZOLES; MALE; MICE; MICE, OBESE; MYOCYTES, CARDIAC; NIFEDIPINE; RECURRENCE; TETRAZOLES; VENTRICULAR REMODELING;

MUS;

EID: 76849107680     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.12.013     Document Type: Article

References (36)

1. Alchanatis M., Tourkohoriti G., Kosmas E.N., Panoutsopoulos G., Kakouros S., Papadima K., Gaga M., Jordanoglou J.B. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. European Respiratory Journal 2002, 20(5):1239-1245.
2. Chen L., Einbinder E., Zhang Q., Hasday J., Balke C.W., Scharf S.M. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. American Journal of Respiratory and Critical Care Medicine 2005, 172(7):915-920.
3. De Mello W.C. Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system. Journal of Molecular and Cellular Cardiology 2004, 37(2):431-438.
4. De Mello W.C., Danser A.H. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension 2000, 35(6):1183-1188.
5. Ducharme A., Frantz S., Aikawa M., Rabkin E., Lindsey M., Rohde L.E., Schoen F.J., Kelly R.A., Werb Z., Libby P., Lee R.T. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. Journal of Clinical Investigation 2000, 106(1):55-62.
6. Fukuo K., Yang J., Suzuki T., Kaimoto T., Takemura Y., Yasuda O., Suhara T., Sato N., Ogihara T. Nifedipine upregulates manganese superoxide dismutase expression in vascular smooth muscle cells via endothelial cell-dependent pathways. Hypertension Research 2003, 26(6):503-508.
7. Gao X., Xu X., Belmadani S., Park Y., Tang Z., Feldman A.M., Chilian W.M., Zhang C. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Atherosclerosis, Thrombosis and Vascular Biology 2007, 27(6):1269-1275.
8. Gassanov N., Brandt M.C., Michels G., Lindner M., Er F., Hoppe U.C. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium 2006, 39(2):175-186.
9. Gilmartin G.S., Tamisier R., Curley M., Weiss J.W. Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. American Journal of Physiology-Heart and Circulatory Physiology 2008, 295(2):H778-H785.
10. Guggilam A., Haque M., Kerut E.K., McIlwain E., Lucchesi P., Seghal I., Francis J. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. American Journal of Physiology-Heart and Circulatory Physiology 2007, 293(1):H599-H609.
11. Okuda N., Hayashi T., Mori T., Inamoto S., Okabe M., Mieno S., Horimoto H., Kitaura Y. Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. Hypertension Research 2005, 28(5):431-438.
12. Hayashi T., Nozawa M., Sohmiya K., Toko H., Nakao M., Okabe M., Terasaki F., Kitaura Y., Kawamura K. Efficacy of pancreatic transplantation on cardiovascular alterations in diabetic rats: an ultrastructural and immunohistochemical study. Transplantation Proceedings 1998, 30(2):335-338.
13. Inamoto S., Hayashi T., Tazawa N., Mori T., Yamashita C., Nakano D., Matsumura Y., Okuda N., Sohmiya K., Sakai A., Furuya E., Kitaura Y. Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. Circulation Journal 2006, 70(6):787-792.
14. Lattimore J.D., Celermajer D.S., Wilcox I. Obstructive sleep apnea and cardiovascular disease. Journal of the American College of Cardiology 2003, 41(9):1429-1437.
15. Li Y.Y., McTiernan C.F., Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovascular Research 2000, 46(2):214-224.
16. Liu Y., Yuan Z., Liu Y., Zhang J., Yin P., Wang D., Wang Y., Kishimoto C., Ma A. PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression. American Heart Journal 2007, 154(4):718-724.
17. 2+ in rat experimental wounds. Journal of Clinical Investigation 1993, 92(5):2368-2376.
18. Miller F.J., Cutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circulation Research 1998, 82(12):1298-1305.
19. Minoguchi K., Tazaki T., Yokoe T., Minoguchi H., Watanabe Y., Yamamoto M., Adachi M. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004, 126(5):1473-1479.
20. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93(2):215-228.
21. Moon S.K., Kang S.K., Kim C.H. Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells. Journal of the Federation of American Societies for Experimental Biology 2006, 20(9):1387-1395.
22. Mori T., Hayashi T., Sohmiya K., Okuda N., Shimomura H., Ohkita M., Matsumura Y., Yoshiyama M., Yoshikawa J., Kitaura Y. Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. Circulation Journal 2005, 69(5):596-602.
23. Nakano D., Hayashi T., Tazawa N., Yamashita C., Inamoto S., Okuda N., Mori T., Sohmiya K., Kitaura Y., Okada Y., Matsumura Y. Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertension Research 2005, 28(10):837-845.
24. Nakashima H., Katayama T., Takagi C., Amenomori K., Ishizaki M., Honda Y., Suzuki S. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. European Heart Journal 2006, 27(19):2317-2322.
25. Poole-Wilson P.A., Lubsen J., Kirwan B.A., van Dalen F.J., Wagener G., Danchin N., Just H., Fox K.A., Pocock S.J., Clayton T.C., Motro M., Parker J.D., Bourassa M.G., Dart A.M., Hildebrandt P., Hjalmarson A., Kragten J.A., Molhoek G.P., Otterstad J.E., Seabra-Gomes R., Soler-Soler J., Weber S. A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004, 364(9437):849-857.
26. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. American Journal of Epidemiology 2004, 160(6):521-530. Sleep Heart Health Study Investigators.
27. Schafer H., Koehler U., Ewig S., Hasper E., Tasci S., Luderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999, 92(2):78-84.
28. Schiller M., Javelaud D., Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. Journal of Dermatological Science 2004, 35(2):83-92.
29. Siwik D.A., Pagano P.J., Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. American Journal of Physiology. Cell Physiology 2001, 280(1):C53-C60.
30. Subramanian V., Krishnamurthy P., Singh K., Singh M. Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice. American Journal of Physiology-Heart and Circulatory Physiology 2007, 292(1):H673-H683.
31. Suzuki J., Iwai M., Li Z., Li J.M., Min L.J., Ide A., Yoshii T., Oshita A., Mogi M., Horiuchi M. Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice. Journal of Hypertension 2005, 23(7):1383-1389.
32. Tsutsui H., Matsushima S., Kinugawa S., Ide T., Inoue N., Ohta Y., Yokota T., Hamaguchi S., Sunagawa K. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Hypertension Research 2007, 30(5):439-449.
33. Yamashita C., Hayashi T., Mori T., Tazawa N., Kwak C., Nakano D., Sohmiya K., Okada Y., Kitaura Y., Matsumura Y. Angiotensin-II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice. Hypertension Research 2007, 30(12):1219-1230.
34. Young T., Skatrud J., Peppard P.E. Risk factors for obstructive sleep apnea in adults. Journal of the American Medical Association 2004, 291(16):2013-2016.
35. Yu C.M., Tipoe G.L., Wing-Hon Lai K., Lau C.P. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. Journal of the American College of Cardiology 2001, 38(4):1207-1215.
36. Zalba G., Fortuño A., Orbe J., San José G., Moreno M.U., Belzunce M., Rodríguez J.A., Beloqui O., Páramo J.A., Díez J. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis. Atherosclerosis, Thrombosis and Vascular Biology 2007, 27(3):587-593.